Drug to Work against Neurodegenerative Disease in Experimental Stage

Drug to Work against Neurodegenerative Disease in Experimental Stage

It has been said that GlaxoSmithKline is working on a drug that can work quite well against the neurodegenerative problems like Alzheimer's, Parkinson's disease.

For now, the research at a preliminary stage, said study researchers. Their drug, GSK2606414, is able to block the disruption that causes neurodegenerative disease. The study has been published in the U. S. journal Science Translational Medicine.

While explaining the entire procedure, study researchers have affirmed that certain diseases starts spreading by developing rogue proteins in the brain. In order to stop the same, the brain goes in to the mode called as the unfolded protein response.

The mechanism is such that it would not allow the brain to make new proteins. But the rogue proteins that are present in the brain try to stop the mechanism from getting switched off. In this scenario, neither, neither misshapen proteins nor normal protein cells are made.

Study researchers are developing a drug that will work by ensuring that production of normal proteins, which is vital for the survival for brain cells. "We're still a long way from a usable drug for humans -- this compound had serious side effects", affirmed Giovanna Mallucci, a professor of toxicology. Other researchers have appreciated the efforts.


FrenchTribune Specials

Windows 10 Anniversary Update will add two advanced security capabilities

The forthcoming Anniversary Update of Microsoft Woindows10 OS will bring along the addition of several new features, including advanced security capabilities which will enable IT managers to more effectively lock down the computers in their organization.

The two new advanced security capabilities which are being added to Windows 10 OS as...

Exxon reports 46% decline in First Quarter earning

On Thursday, Exxon reported a 46% decline in earnings in the first quarter, by earning $4.9 billion compared with $9.1 billion in the same quarter a year ago. Exxon's top and bottom lines declined due to lower oil prices.

It was the...

Most Popular

Study finds no link between IVF and risk of breast cancer

A new study claimed that women who undergo in-vitro...

Nvidia unveils its latest flagship graphics card --- Titan X

Chip maker Nvidia has unveiled its newest flagship...

Nail biting and thumb-sucking might be healthy for children

To all those parents who have tough time in making their...

Facebook Messenger app grows to more than 1 billion users

On Wednesday, social network Facebook announced that its...

Poll

Can Greece Come out of Economic Problems: